|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00954 CHANGMAO BIO
Nominal 
0.320 0.000 (0.000%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 272,278 | -13.233% | 584,794 | 637,078 | 730,034 | 547,976 |
| Cost of Sales | (259,127) | -12.991% | (568,017) | (611,269) | (549,203) | (509,296) |
| Gross Profit | 13,151 | -17.739% | 16,777 | 25,809 | 180,831 | 38,680 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (205) | (183) | 136 | (28) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (25,239) | 44.702% | (67,582) | (58,580) | 87,644 | 84,409 | |
| Taxation | (748) | -34.039% | (669) | (27,938) | (6,286) | (26,202) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 197 | -- | 8 | 461 | 65 | 111 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (25,790) | 37.283% | (68,243) | (86,057) | 81,423 | 58,318 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 5,754 | 100.488% | 10,514 | 6,532 | 1,729 | 1,415 |
| Depreciation & Amortisation | 24,745 | 11.968% | 45,616 | 42,745 | 32,202 | 29,214 |
| Directors' Emoluments | -- | -- | 1,987 | 1,979 | 6,615 | 1,831 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -4.900 | 40.000% | -12.900 | -16.200 | 15.400 | 11.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 7.700 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | 50.000% | -- |
| Cash flow per share ($) | -- | -- | (0.061) | (0.004) | 0.037 | (0.013) |
| NBV per share ($) | 1.053 | -- | 1.101 | 1.230 | 1.470 | 1.316 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -25,790 |
| %Change | 37.283% |
| EPS / (LPS) | RMB -0.049 |
| NBV Per Share (¥) | RMB 1.053 |